3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis
Open Access
- 16 November 2012
- journal article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 10 (1) , 247
Abstract
Background: Recent studies have indicated that the nuclear RNA-binding protein RBM5 has the ability to modulate apoptosis and suppress tumor growth. The aim of this study is to investigate the expression of RBM5 in human prostate cancer and its mechanism of tumor suppression. Methods: The expression of RBM5 protein in cancerous prostatic tissues and normal tissues was examined by IHC. PC-3 cell line was used to determine the apoptotic function of RBM5 in vitro. PC-3 cells were transiently transfected with pcDNA3.1-RBM5. Cell viability was determined by MTT assay. Rhodamine 123 staining and Annexin V analysis were performed to observe the apoptotic activity of PC-3 cells overexpressing RBM5. Expression of apoptosis-related genes was assessed by western blot. Results: The expression of RBM5 protein was significantly decreased in cancerous prostatic tissues compared to the normal tissues. PC-3 cells overexpressing RBM5 showed not only significant growth inhibition compared with the vector controls, but also dysfunction of mitochondrial membrane potential and increased apoptotic activity. To further define RBM5 function in apoptotic pathways, we investigated differential expression profiles of various BH3-only proteins including Bid, Bad, and Bim, and apoptosis regulatory proteins include P53, cleaved caspase9, and cleaved caspase3. We found that the expression of both BH3-only proteins and apoptosis regulatory proteins was increased in RBM5 transfected cells. Conclusion: The expression of RBM5 protein was significantly decreased in cancerous prostatic tissues, which suggests that RBM5 plays an important role in the pathogenesis of prostate cancer. RBM5 may induce the apoptosis of prostate cancer PC-3 cells by modulating the mitochondrial apoptotic pathway, and thus RBM5 might be a promising target for gene therapy on prostate cancer.Keywords
This publication has 33 references indexed in Scilit:
- International Variation in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2012
- Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in ChinaAsian Journal of Andrology, 2008
- 3p21.3 tumor suppressor cluster: prospects for translational applicationsFuture Oncology, 2005
- Localized prostate cancer: radiation or surgery?Urologic Clinics of North America, 2003
- Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta‐6 of the candidate tumour suppressor LUCA‐15/RBM5Genes to Cells, 2003
- cDNA Microarray Analysis of Vestibular SchwannomasOtology & Neurotology, 2002
- A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.2002
- LUCA15, a putative tumour suppressor gene encoding an RNA‐binding nuclear protein, is down‐regulated in ras‐transformed Rat‐1 cellsGenes to Cells, 2000
- High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.2000
- Deletions of the Short Arm of Chromosome 3 in Solid Tumors and the Search for Suppressor Genes1997